West China Hospital

This early-phase study tests a new immune-based treatment for people with advanced cancers that are positive for the Epstein-Barr virus (EBV). The main goal is to check if the treatment is safe and to see how well it might shrink tumors or slow the disease. Only 6 patients who ha…

This early-phase study tests whether giving two drugs—camrelizumab and palbociclib—before surgery is safe and feasible for people with a type of esophageal cancer that can be removed. The trial involves 6 participants and focuses on side effects and whether the treatment delays s…

This early-phase study tests whether taking a specific probiotic (Akkermansia) alongside an immunotherapy drug (anti-PD-1) is safe and feasible for people with advanced colorectal cancer that hasn't responded to standard treatments. The trial involves 22 adults aged 18-75. Resear…

This early study tests a single infusion of a drug called JWK007 in 3 boys aged 5 to 10 with Duchenne muscular dystrophy. The main goal is to see if the drug is safe and tolerable. Researchers will also check if it helps with muscle function, but this is not a cure and ongoing ma…

This study aimed to see if adding a low dose of radiation to a combination of targeted and immunotherapy drugs before surgery works better than using the drugs alone for head and neck cancer. The goal was to shrink tumors more effectively to improve surgical outcomes and potentia…

This study tests whether a spirulina-derived product can prevent or treat severe mouth sores caused by radiation therapy in people with head and neck cancer. About 70 participants will receive either the spirulina product or a placebo during their radiation treatment. The goal is…

This study looks at 300 women who had immediate breast reconstruction with implants after mastectomy. Researchers want to understand why some women develop capsular contracture, a condition where scar tissue tightens around the implant, causing pain or distortion. The goal is to …

This study tests whether a game-based teaching method helps neurology residents remember key information longer and make better decisions compared to traditional lectures. About 240 residents will wear wristbands that measure stress and attention, and use a digital platform to ea…

This study looks at 500 people with advanced neuroendocrine tumors to find the best order of two treatments: surufatinib and somatostatin analogs. Researchers compare starting with surufatinib then switching to somatostatin analogs versus the opposite order. The goal is to see wh…